Fazila Asmar

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Nuclear medicine in hematology: Bridging diagnostics and therapy.

Nuclear medicine in hematology: Bridging diagnostics and therapy.

Journal: Clinical physiology and functional imaging

Published: August 15, 2024

Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes.

Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 06, 2023

Profiling of ribose methylations in ribosomal RNA from diffuse large B-cell lymphoma patients for evaluation of ribosomes as drug targets.

Profiling of ribose methylations in ribosomal RNA from diffuse large B-cell lymphoma patients for evaluation of ribosomes as drug targets.

Journal: NAR cancer

Published: July 22, 2020

Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma.

Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma.

Journal: American journal of hematology

Published: July 25, 2019

Publisher Correction: Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations.

Publisher Correction: Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations.

Journal: Scientific reports

Published: November 22, 2018

Human adult HSCs can be discriminated from lineage-committed HPCs by the expression of endomucin.

Human adult HSCs can be discriminated from lineage-committed HPCs by the expression of endomucin.

Journal: Blood advances

Published: January 05, 2018

Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner.

Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner.

Journal: Molecular oncology

Published: July 25, 2017

Twin DNA Methylation Profiling Reveals Flare-Dependent Interferon Signature and B Cell Promoter Hypermethylation in Systemic Lupus Erythematosus.

Twin DNA Methylation Profiling Reveals Flare-Dependent Interferon Signature and B Cell Promoter Hypermethylation in Systemic Lupus Erythematosus.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 08, 2017

Global hypomethylation is an independent prognostic factor in diffuse large B cell lymphoma.

Global hypomethylation is an independent prognostic factor in diffuse large B cell lymphoma.

Journal: American journal of hematology

Published: January 05, 2017

Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations.

Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations.

Journal: Scientific reports

Published: December 08, 2016

TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.

TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.

Journal: Acta neuropathologica communications

Published: March 27, 2016

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.

Journal: Blood

Published: March 08, 2016

Showing 1-12 of 21

Last Updated: 09/26/2026